Cannabis Transdermal Patch
Discover the convenience of the Cannabis Transdermal Patch for a discreet and effective way to manage your wellness.
A small number of cannabis brands sell a patch labeled transdermal in US dispensaries. The two best known are Mary's (Mary's Medicinals) and Papa & Barkley. Both sell through licensed state markets, not nationwide. What you find on the shelf depends on your state's inventory and its dose rules.
A transdermal patch moves cannabinoids through the skin and into the bloodstream. A topical balm or lotion stays in the skin and the tissue under it. That changes onset and duration. Patch onset runs 15 minutes to 1 hour. Effects last 8 to 12 hours on most products. Topicals produce little to no detectable blood THC in most users.
thc transdermal patch for sale
Colorado company, founded 2013. Mary's lists its patch as one of the earliest cannabis transdermal products on the US market. The patch carries 10 mg THC, 10 mg CBD, or a 1:1 blend. Some versions pair THC with CBN. Wear time is 12 hours.
Cannabis Transdermal Patches: A Comparison Buying Guide
California brand. Releaf Transdermal Patch, sold in 30 mg THC and 1:1 THC:CBD strengths. Wear time is 12 hours. Distribution covers California and Colorado, plus a few other licensed states.
Multi-state operators list patches in select markets. Trulieve sells patches in Florida. Curaleaf sells patches in several Northeast states. Formulas and doses vary by state because each market writes its own rules. A 10 mg patch in one state can be a 20 mg patch in another.
Most single patches hold 10 mg THC. Some hold 20 mg or 30 mg. Cutting a patch is not advised. The drug sits in an adhesive matrix that does not divide into equal parts. New THC users should ask the dispensary for the lowest dose on hand. The patch releases for the full wear time, so a high dose lasts hours longer than a vape hit.
Single patches retail from $10 to $30. Multi-packs run $60 to $120. Price tracks THC content and state taxes. Medical patients in some states pay a lower tax rate.
No cannabis transdermal patch carries FDA approval. The FDA has approved one cannabis-derived drug, CBD-based Epidiolex, and no patch product. Dispensary patches fall under state medical and adult-use programs. Skin redness under the patch is the most common complaint. Rotate placement sites between uses.